Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis

BACKGROUND: A number of circulating plasma biomarkers have been shown to predict survival in patients with idiopathic pulmonary fibrosis (IPF), but most were identified before the use of antifibrotic (AF) therapy in this population. Because pirfenidone and nintedanib have been shown to slow IPF prog...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Chest
Main Authors: Adegunsoye, Ayodeji, Alqalyoobi, Shehabaldin, Linderholm, Angela, Bowman, Willis S., Lee, Cathryn T., Pugashetti, Janelle Vu, Sarma, Nandini, Ma, Shwu-Fan, Haczku, Angela, Sperling, Anne, Strek, Mary E., Noth, Imre, Oldham, Justin M.
Formato: Artigo
Idioma:Inglês
Publicado em: American College of Chest Physicians 2020
Assuntos:
Diffuse Lung Disease: Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7545483/
https://ncbi.nlm.nih.gov/pubmed/32450241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chest.2020.04.066
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados